13 Analysts Have This To Say About Elevance Health
Portfolio Pulse from Benzinga Insights
Analysts have mixed opinions on Elevance Health (NYSE:ELV), with a recent decrease in the average 12-month price target by 1.3%. The company faces challenges with a slight revenue decline but maintains strong profitability metrics. Analyst ratings vary from 'Overweight' to 'Neutral', reflecting diverse market sentiments.
September 05, 2024 | 7:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Elevance Health (NYSE:ELV) has received mixed analyst ratings, with a slight decrease in the average price target by 1.3%. Despite a small revenue decline, the company shows strong profitability metrics. Analysts' ratings range from 'Overweight' to 'Neutral', indicating varied market sentiments.
The article provides a detailed analysis of analyst ratings for Elevance Health, showing a slight decrease in the average price target. The company's strong profitability metrics are offset by a small revenue decline, leading to mixed analyst sentiments. This results in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100